Skip to main content
. 2021 Jun 17;65(7):e00316-21. doi: 10.1128/AAC.00316-21

TABLE 3.

Summary of RV94 and comparator in vitro microbiological activity against 74 Gram-positive organisms determined by broth microdilution

Organism Typea No. of isolates RV40b
RV94
Telavancin
Vancomycin
MIC (μg/ml) MIC:MBC MIC (μg/ml) MIC:MBC MIC (μg/ml) MIC:MBC MIC (μg/ml) MIC:MBC
Gram-positive aerobes
    S. aureus MSSA 4 0.012 1 0.023 8 0.09 1 0.75 1
    S. aureus MRSA 12 0.008 1 0.015 1 0.06 1 0.5 1
    S. aureus hVISA 2 0.023 1 0.08 8 0.19 1 1.5 1
    S. aureus VISA 5 0.06 1 0.12 2 0.25 1 4 4
    S. aureus VRSA 12 NT NT 4 NT NT NT >64 NT
    Staphylococcus epidermidis MSSE 1 0.015 NT 0.015 NT 0.12 NT 0.5 NT
    S. epidermidis MRSE 2 0.008 1 0.03 1 0.12 1 1 1
    Staphylococcus lugdunensis 1 0.004 NT 0.015 NT 0.06 NT 0.25 NT
    Staphylococcus haemolyticus 1 0.015 NT 0.06 NT 0.06 NT 1 NT
    Staphylococcus hominis 1 0.015 NT 0.03 NT 0.06 NT 0.5 NT
    Enterococcus faecalis VSE 2 0.023 >8 0.03 >8 0.19 >8 1.5 >8
    E. faecalis VanA VRE 1 0.5 8 0.03 >8 1 8 128 NT
    Enterococcus faecium VSE 1 0.004 NT 0.015 NT 0.06 NT 0.5 NT
    E. faecium VanA VRE 1 1 >4 2 >8 2 >4 128 NT
    E. faecium VanB VRE 1 0.008 >8 0.03 >8 0.06 >8 64 >2
    Streptococcus pneumoniae PISP 2 0.004 1 0.006 4 0.02 1 0.6 8
    S. pneumoniae PRSP 1 ≤0.008 NT 0.008 NT 0.03 NT 0.25 NT
    Streptococcus pyogenes 2 0.04 NT 0.012 NT 0.06 NT 0.25 NT
    S. pyogenes ermR 1 0.008 1 0.008 1 0.06 1 1
    Streptococcus agalactiae 2 0.008 1 0.02 4 0.06 >8 0.25 4
    S. agalactiae ermR 1 0.008 NT 0.004 NT 0.06 NT 0.25 NT
    Streptococcus dysgalactiae 3 0.015 1 0.008 4 0.12 4 0.25 >8
    Streptococcus anginosus AGS 1 0.015 >8 0.015 >8 0.06 >8 0.5 >8
    Streptococcus constellatus AGS 1 0.008 NT 0.008 NT 0.03 NT 0.25 NT
    Streptococcus mitis MGS 2 0.02 1 0.008 1 0.05 1 0.25 1
    Streptococcus oralis MGS 1 0.015 NT 0.015 NT 0.06 NT 0.5 NT
Gram-positive anaerobes
    Clostridioides difficile toxAB- 1 0.06 NT 0.015 NT 0.12 NT 0.25 NT
    C. difficile ribo 027 1 0.06 NT 0.015 NT 0.12 NT 0.5 NT
    C. difficile NAP1;ribo 027 1 0.12 NT 0.06 NT 0.12 NT 1 NT
    Clostridium. perfringens 1 0.015 NT 0.008 NT 0.015 NT 0.25 NT
    Peptostreptococcus micros 1 0.06 NT NT NT 0.12 NT NT NT
    Peptostreptococcus anaerobius 1 0.008 NT 0.008 NT 0.03 NT 0.12 NT
    Cutibacterium acnes 2 0.008 NT 0.008 NT 0.02 NT 0.19 NT
    Eggerthella lenta 1 NT NT 0.008 NT NT NT 0.5 NT
a

MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant S. aureus; hVISA, heterogeneous vancomycin-intermediate S. aureus; VISA, vancomycin-intermediate S. aureus; VRSA, vancomycin-resistant S. aureus, MSSE, methicillin-susceptible S. epidermidis; MRSE, methicillin-resistant S. epidermidis; VSE, vancomycin-susceptible enterococci; VanA VRE, VanA-type vancomycin-resistant enterococci (vancomycin- and teicoplanin-resistant); VanB VRE, VanB-type vancomycin-resistant enterococci (vancomycin-resistant and teicoplanin-susceptible); PISP, penicillin-intermediate S. pneumoniae; PRSP, penicillin-resistant S. pneumoniae; ermR, erythromycin-resistant; AGS, anginosus group streptococci; MGS, mitis group streptococci; NT, not tested.

b

MIC listed in the cells is the median MIC value. The MBC was measured on one organism and type except for MRSA, where the MBC represents the median of n = 5, and VISA, where it represents the median of n = 2. MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration.